46 research outputs found

    Metabolic Changes Associated With Second-Generation Antipsychotic Use in Alzheimer’s Disease Patients: The CATIE-AD Study

    Get PDF
    The second-generation antipsychotics are associated with metabolic abnormalities in patients with schizophrenia. Elderly patients with Alzheimer’s disease are frequently treated with these antipsychotics but there is little data available on their metabolic effects

    The physician's unique role in preventing violence: a neglected opportunity?

    Full text link

    Neuroimaging and the Origin of Psychiatric Symptoms in Dementia

    No full text
    corecore